According to ASLAN Pharmaceuticals's latest financial reports the company has $21.25 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $56.9 M | -36.89% |
2021-12-31 | $90.16 M | 529.47% |
2020-12-31 | $14.32 M | -35.48% |
2019-12-31 | $22.2 M | -23.2% |
2018-12-31 | $28.9 M | -42.84% |
2017-12-31 | $50.57 M | -1.91% |
2016-12-31 | $51.55 M | 95.96% |
2015-12-31 | $26.3 M | 371.74% |
2014-12-31 | $5.57 M |